NO980171L - Anvendelse av 1,4-dihydropyridin-derivater ved forebyggelse av behandling av aterosklerotisk nedbrytning av arterie-vegger - Google Patents
Anvendelse av 1,4-dihydropyridin-derivater ved forebyggelse av behandling av aterosklerotisk nedbrytning av arterie-veggerInfo
- Publication number
- NO980171L NO980171L NO980171A NO980171A NO980171L NO 980171 L NO980171 L NO 980171L NO 980171 A NO980171 A NO 980171A NO 980171 A NO980171 A NO 980171A NO 980171 L NO980171 L NO 980171L
- Authority
- NO
- Norway
- Prior art keywords
- arterial walls
- prevention
- lercanidipine
- treatment
- atherosclerotic
- Prior art date
Links
- 230000003143 atherosclerotic effect Effects 0.000 title abstract 3
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical class C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title abstract 2
- 230000015556 catabolic process Effects 0.000 title abstract 2
- 238000006731 degradation reaction Methods 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- ZDXUKAKRHYTAKV-MGBGTMOVSA-N 5-o-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-o-methyl (4r)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound C1([C@H]2C(=C(C)NC(C)=C2C(=O)OC)C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=CC([N+]([O-])=O)=C1 ZDXUKAKRHYTAKV-MGBGTMOVSA-N 0.000 abstract 1
- ZDXUKAKRHYTAKV-XIFFEERXSA-N 5-o-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-o-methyl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound C1([C@@H]2C(=C(C)NC(C)=C2C(=O)OC)C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=CC([N+]([O-])=O)=C1 ZDXUKAKRHYTAKV-XIFFEERXSA-N 0.000 abstract 1
- 102000007330 LDL Lipoproteins Human genes 0.000 abstract 1
- 108010007622 LDL Lipoproteins Proteins 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- ZDXUKAKRHYTAKV-UHFFFAOYSA-N lercanidipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZDXUKAKRHYTAKV-UHFFFAOYSA-N 0.000 abstract 1
- 229960004294 lercanidipine Drugs 0.000 abstract 1
- 210000002540 macrophage Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000013508 migration Methods 0.000 abstract 1
- 230000005012 migration Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 210000000107 myocyte Anatomy 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 231100000216 vascular lesion Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
,4-dihydropyridiner har blitt funnet å motvirke flere prosesser som spiller en rolle ved utviklin-gen av aterosklerotiske vaskulære lesjoner såsom myocytt-proliferasjon og -migrering, kolesterol-omsetning i makrofager og oksydativ modifisering av lavtetthets-lipoproteiner. De er følgelig anvende-lige ved fremstilling av medikamenter for å forhin-dre, stoppe og reversere aterosklerotisk nedbryt-ning i arteriveggene hos mennesker. De foretrukne 1,4-dihydropyridiner for dette formål er lerkanidi-pin, (S)-lerkanidipin og (R)-lerkanidipin.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI951513A IT1275532B (it) | 1995-07-14 | 1995-07-14 | Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa |
| PCT/EP1996/002872 WO1997003669A1 (en) | 1995-07-14 | 1996-06-28 | Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO980171L true NO980171L (no) | 1998-01-14 |
| NO980171D0 NO980171D0 (no) | 1998-01-14 |
Family
ID=11371972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO980171A NO980171D0 (no) | 1995-07-14 | 1998-01-14 | Anvendelse av 1,4-dihydropyridin-derivater ved forebyggelse av behandling av aterosklerotisk nedbrytning av arterie-vegger |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0839036B1 (no) |
| JP (1) | JPH11509214A (no) |
| KR (1) | KR19990028741A (no) |
| CN (1) | CN1190345A (no) |
| AT (1) | ATE183644T1 (no) |
| AU (1) | AU690471B2 (no) |
| CA (1) | CA2219501A1 (no) |
| CZ (1) | CZ11698A3 (no) |
| DE (1) | DE69603968T2 (no) |
| DK (1) | DK0839036T3 (no) |
| ES (1) | ES2138359T3 (no) |
| GR (1) | GR3031096T3 (no) |
| HU (1) | HUP9802736A3 (no) |
| IL (1) | IL122302A (no) |
| IT (1) | IT1275532B (no) |
| NO (1) | NO980171D0 (no) |
| SK (1) | SK4198A3 (no) |
| WO (1) | WO1997003669A1 (no) |
| ZA (1) | ZA965924B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6852737B2 (en) | 2001-08-06 | 2005-02-08 | Recordati Ireland Limited | Crude and crystalline forms of lercanidipine hydrochloride |
| ITMI20011726A1 (it) * | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Forme polimorfe della lercanidipina cloridrato |
| TW200613275A (en) * | 2004-08-24 | 2006-05-01 | Recordati Ireland Ltd | Lercanidipine salts |
| AR053023A1 (es) * | 2005-02-25 | 2007-04-18 | Recordati Ireland Ltd | Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen |
| EA027787B1 (ru) | 2010-06-23 | 2017-09-29 | Крка, Товарна Здравил, Д.Д., Ново Место | Пероральные лекарственные формы, содержащие лерканидипин и эналаприл и их фармацевтически приемлемые соли |
| PL2627173T5 (pl) | 2010-10-12 | 2019-11-29 | Chiesi Farm Spa | Formulacje emulsyjne klewidypiny zawierające środki przeciw mikrobom |
| US8658676B2 (en) | 2010-10-12 | 2014-02-25 | The Medicines Company | Clevidipine emulsion formulations containing antimicrobial agents |
| WO2012085249A2 (en) | 2010-12-24 | 2012-06-28 | Krka, D.D., Novo Mesto | Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
-
1995
- 1995-07-14 IT ITMI951513A patent/IT1275532B/it active IP Right Grant
-
1996
- 1996-06-28 EP EP96924834A patent/EP0839036B1/en not_active Expired - Lifetime
- 1996-06-28 AU AU65164/96A patent/AU690471B2/en not_active Ceased
- 1996-06-28 HU HU9802736A patent/HUP9802736A3/hu unknown
- 1996-06-28 KR KR1019980700039A patent/KR19990028741A/ko not_active Withdrawn
- 1996-06-28 CA CA002219501A patent/CA2219501A1/en not_active Abandoned
- 1996-06-28 CZ CZ98116A patent/CZ11698A3/cs unknown
- 1996-06-28 IL IL12230296A patent/IL122302A/xx not_active IP Right Cessation
- 1996-06-28 CN CN96195439A patent/CN1190345A/zh active Pending
- 1996-06-28 DK DK96924834T patent/DK0839036T3/da active
- 1996-06-28 WO PCT/EP1996/002872 patent/WO1997003669A1/en not_active Ceased
- 1996-06-28 SK SK41-98A patent/SK4198A3/sk unknown
- 1996-06-28 ES ES96924834T patent/ES2138359T3/es not_active Expired - Lifetime
- 1996-06-28 DE DE69603968T patent/DE69603968T2/de not_active Expired - Fee Related
- 1996-06-28 JP JP9506222A patent/JPH11509214A/ja active Pending
- 1996-06-28 AT AT96924834T patent/ATE183644T1/de not_active IP Right Cessation
- 1996-07-12 ZA ZA965924A patent/ZA965924B/xx unknown
-
1998
- 1998-01-14 NO NO980171A patent/NO980171D0/no not_active Application Discontinuation
-
1999
- 1999-08-26 GR GR990402179T patent/GR3031096T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9802736A3 (en) | 2000-03-28 |
| DE69603968T2 (de) | 2000-04-06 |
| EP0839036B1 (en) | 1999-08-25 |
| CA2219501A1 (en) | 1997-02-06 |
| ES2138359T3 (es) | 2000-01-01 |
| CN1190345A (zh) | 1998-08-12 |
| ZA965924B (en) | 1997-01-30 |
| HUP9802736A2 (hu) | 1999-03-29 |
| KR19990028741A (ko) | 1999-04-15 |
| SK4198A3 (en) | 1998-05-06 |
| WO1997003669A1 (en) | 1997-02-06 |
| DE69603968D1 (de) | 1999-09-30 |
| GR3031096T3 (en) | 1999-12-31 |
| IL122302A0 (en) | 1998-04-05 |
| CZ11698A3 (cs) | 1998-06-17 |
| IL122302A (en) | 2000-08-13 |
| ATE183644T1 (de) | 1999-09-15 |
| IT1275532B (it) | 1997-08-07 |
| JPH11509214A (ja) | 1999-08-17 |
| ITMI951513A1 (it) | 1997-01-14 |
| DK0839036T3 (da) | 2000-01-24 |
| NO980171D0 (no) | 1998-01-14 |
| EP0839036A1 (en) | 1998-05-06 |
| AU6516496A (en) | 1997-02-18 |
| ITMI951513A0 (it) | 1995-07-14 |
| AU690471B2 (en) | 1998-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR017639A1 (es) | Procedimiento de la alquilacion directa en una etapa, en las posiciones 7 y 10 simultaneamente de las dos funciones hidroxilos de la 10-desacetilbacatina o de los derivados de esta ultima esterificados en la posicion 13. | |
| DE69509650D1 (de) | Behandlung atrialer fibrillationen | |
| NO982311D0 (no) | Sammensetninger og fremgangsmÕter for forhindring og behandling av oral mukositt | |
| NO981817L (no) | Indolin-2-on-derivater, fremgangsmÕte for fremstilling av dem og farmas÷ytiske blandinger inneholdende dem | |
| NO981810D0 (no) | Sammensetninger og fremgangsmÕter for behandling av tilstander ved bensvikt | |
| DK1920773T3 (da) | Thalidomid og dexamethason til behandling af tumorer | |
| DE59508891D1 (de) | Hautpflegemittel | |
| AU6914296A (en) | Left coronary artery catheter | |
| NO980171L (no) | Anvendelse av 1,4-dihydropyridin-derivater ved forebyggelse av behandling av aterosklerotisk nedbrytning av arterie-vegger | |
| AU2001284413A1 (en) | Medicinal compositions for preventing or treating heart failure | |
| CA2180535A1 (en) | A method for treatment of psoriasis, by omeprazole or related compounds | |
| NO964486D0 (no) | Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering | |
| ZA9610722B (en) | Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases | |
| AU1367597A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of benign prostatic hypertrophy | |
| AU1367397A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes | |
| NO986058D0 (no) | Ikke-lineµre redusert-fasefiltere for aktiv st÷ykontroll | |
| EP0684951A1 (en) | SILYL ACETYLCHOLINESTERASE INHIBITORS. | |
| HUP9902683A3 (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms | |
| CA2343299A1 (en) | Method for preventing or delaying catheter-based revascularization | |
| RU96112829A (ru) | Способ лечения ишемической болезни сердца | |
| NO982562L (no) | Sammensetning for behandling av smerte | |
| AU4328996A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity | |
| TW372962B (en) | Pharmaceutical compositions for the prevention, arrest or reversal of atherosclerotic degradation in the arterial walls of a patient | |
| FR2725720B1 (fr) | Derives metalloceniques du diarylethylene, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits derives | |
| NO953322D0 (no) | Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |